Supplemental material
Drug Delivery
Volume 26, 2019 - Issue 1
Related Research Data
Controlled nail delivery of a novel lipophilic antifungal agent using various modern drug carrier systems as well as in vitro and ex vivo model systems.
Source:
Elsevier BV
Onychomycosis in children. A review.
Source:
Wiley
Evaluation of transcutol as a clonazepam transdermal permeation enhancer from hydrophilic gel formulations.
Source:
Elsevier BV
Efinaconazole topical solution, 10%: formulation development program of a new topical treatment of toenail onychomycosis.
Source:
Elsevier BV
Enhancement of transdermal drug delivery via synergistic action of chemicals
Source:
Elsevier B.V.
Enhanced antifungal activity of voriconazole-loaded nanostructured lipid carriers against Candida albicans with a dimorphic switching model.
Source:
Dove Medical Press
Pilot Study to Evaluate the Effect of Topical Dimethicone on Clinical Signs and Skin Barrier Function in Dogs with Naturally Occurring Atopic Dermatitis
Source:
Hindawi Publishing Corporation
Carbon nanotube membranes to predict skin permeability of compounds.
Source:
Taylor & Francis
In vivo transungual iontophoresis: effect of DC current application on ionic transport and on transonychial water loss.
Source:
Elsevier BV
CONGENITAL MALFORMATIONS IN AN INFANT BORN TO A WOMAN TREATED WITH FLUCONAZOLE
Source:
Ovid Technologies (Wolters Kluwer Health)
Efinaconazole in the treatment of onychomycosis
Source:
Informa UK Limited
Solid lipid nanoparticles for antifungal drugs delivery for topical applications
Source:
Future Science Ltd
Comparison of In Vitro Antifungal Activities of Efinaconazole and Currently Available Antifungal Agents against a Variety of Pathogenic Fungi Associated with Onychomycosis
Source:
American Society for Microbiology
The Impact of Onychomycosis on Quality of Life: A Systematic Review of the Available Literature.
Source:
S. Karger AG
Linking provided by
